EVALUATION OF THE MACROMOLECULAR STRUCTURE OF CARDIAC MYOCYTES IN PATIENTS WITH VARIOUS FORMS OF CARDIOMYOPATHY
https://doi.org/10.15825/1995-1191-2012-2-32-42
Abstract
Assessing the condition of the structural proteins of cardiomyocytes in patients with various forms of cardiomyo- pathy (49 samples) revealed changes characteristic for dilated cardiomyopathy, as well as common disorders of the molecular structure, developing, regardless of the etiology of the disease.
About the Authors
A. G. Kupriyanova
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
L. V. Beletskaya
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
V. A. Zaidenov
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
R. Sh. Saitgareev
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
A. M. Golts
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
V. M. Zakharevich
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
S. V. Gautier
Academican V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
References
1. Белецкая Л.В., Куприянова А.Г., Ильинский И.М., Се- верин В.В. Молекулярно-биологическая структура кардиомиоцита // Вестник трансплантологии и ис- кусственных органов. 2006. No 4. С. 89–94.
2. Белецкая Л.В., Куприянова А.Г., Куренкова Л.Г., Гольц А.М., Кормер А.Я. Изменения макромолекуляр- ной структуры кардиомиоцитов при идиопатической кардиомиопатии // Вестник трансплантологии и ис- кусственных органов. 2007. Т. 34. No 2. С. 33–35.
3. Благова О.В., Недоступ А.В., Коган Е.А. и др. Дилата- ционная кардиомиопатия как клинический синдром: опыт нозологической диагностики с использованием биопсии и подходы к лечению // Терапевтический ар- хив. 2011. Т. 83. No 9. С. 41–48.
4. Иткин Г.П., Трухманов С.Б., Шемакин С.Ю. и др. Применение вспомогательных насосов для восста- новления функции миокарда у пациентов с хрониче- ской сердечной недостаточностью // Вестник транс- плантологии и искусственных органов. 2011. No 3. С. 82–85.
5. Румянцев П.П. Кардиомиоциты в процессах диффе- ренцировки и регенерации. Ленинград: Наука. 1982. 315 с.
6. Beletskaya L.V., Kupriyanova A.G., Zaidenov V.A. et al. Altered cytoskeletal protein localization in cardiomyo- cytes of idiopathic cardiomyopathy patients // J. Heart. Lung. Transplant. Aug. 2007. Vol. 26. No 8. P. 868–870.
7. Aquila L.A., McCarthy P.M., Smedira N.G. et al. Cyto- skeletal structure and recovery in single human cardi- ac myocytes // J Heart Lung Transplant. 2004. Vol. 8. P. 954–963.
8. Bergmann O., Bhardwaj R.D., Bernard S. et al. Evidence for cardiomyocyte renewal in humans // Science. 2009. Vol. 324. P. 98–102.
9. Borrmann C.M., Grund C., Kuhn C. et al. The area com- posita of adhering junctions connecting heart muscle cells of vertebrates. II. Colocalizations of desmosomal and fascia adhaerens molecules in the intercalated disk // Eur. J. Cell. Biol. 2006.
10. CaforioA.L.,GrazziniM.,MannJ.M.etal.Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy // Cir- culation. 1992. Vol. 85. P. 1734–1742.
11. CaforioA.L.,CalabreseF.,AngeliniA.etal.Aprospective study of biopsy-proven myocarditis: prognostic relevan- ce of clinical and aetiopathogenetic features at diagnisis // European Heart Journal. 2007. Vol. 28. P. 1326–1333.
12. Chang A.N. and Potter J.D. Sarcomeric Protein Muta- tions in Dilated Cardiomyopathy // Heart Failure Re- views. 2005. Vol. 10. P. 225–235.
13. Chang A.N., Parvatiyar M.S., Potter J.D. Troponin and cardiomyopathy // Biochemical and Biophysical Re- search Communications. 2008. Vol. 369. P. 74–81.
14. Charron P. Clinical genetics in cardiology // Heart. 2006. Vol. 92. P. 1172–1176.
15. Di Somma S., Marotta M., Salvatore G. et al. Changes in myocardial cytoskeletal intermediate filaments and myocy- te contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans // Heart. 2000. Vol. 84. P. 659–667.
16. Di Somma S., Di Beneditto M.P., Slavatore G., et al. Des- min-free cardiomyocytes and myocardial dysfunction in end stage heart failure // Eur. J. Heart. Fail. 2004. Vol. 6. P. 389–398.
17. Ehler E., Perriard J.K. Cardiomyocyte cytoskeleton and myofibrilogenesis in healthy and diseased heart // Heart Fail Rev. 2000. Vol. 3. P. 259–269.
18. Franke W.W., Borrmann С.М., Grund C., Pieperhoff S. The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardio-myocytes by immunoelec- tron microscopy of desmosomal proteins // Eur. J. Cell. Biol. 2006. Vol. 85. No 2. P. 69–82.
19. Grogan M., Redfield M.M., Bailey K.R. et al. Long-term outcome of patients with biopsy-proven myocarditis: comparision with idiopathic dilated cardiomyopathy // J. Am. Coll. Cardiol. 1995. Vol. 26. P. 80–84.
20. Hein S., Kostin S., Heling A. et al. The role of cytoske- leton in heart failure // Cardiovascular Research. 2000. Vol. 45. P. 273–278.
21. Herman D.S., Lam L., Taylor M.R. et al. Truncations of titin causing dilated cardiomyopathy // N. Engl. J. Med. 2012. Feb 16. Vol. 336 (7). P. 619–628.
22. Kostin S., Scholz D., Shimada T. et al. The internal and external protein scaffold of the T-tubular system in cardi- omyocytes // Cell Tissue Res. 1998. Vol. 294. P. 449–460.
23. Kostin S., Hein S., Arnon E., Scholz D., Schaper J. The cytoskeleton and related proteins in human failing heart // Heart Fail. Rev. 2000. Vol. 3. P. 271–280.
24. Luk A., Ahn E., Soor GS et al. Dilated cardiomyopathy: a review// J. Clin. Pathol. 2009. Vol. 62. P. 219–225.
25. Maron B.J., Towbin J.A., Thiene G. et al. Contemporary Definitions and Classification of the Cardiomyopathies // Circulation. 2006. Vol. 113. P. 1807–1816.
26. Piepernoff S., Barth M., Rickelt S., Franke W.W. Desmoso- mal Molecules In and Out of Adhering Junctions: Normal and Diseased States of Epidermal, Cardiac and Mesenchy- mally Derived Cells // Dermatol. Res Pract. Volume 2010, Article ID 139167, 12 pages, doi:10.1155/2010/139167
27. Shaper J., Froede R., Hein St. et al. Impairmant of the myocardial ultrastructure and changes of the cytoske- leton in dilated cardiomyopathy // Circulation. 1991. Vol. 83. No 2. P. 504–505.
28. Urbanek K., Torella D., Sheikh F. et al. Myocardial rege- neration by activation of multipotent cardiac stem cells in ishemic heart failure // Proc Natl Acad Sci USA, 2005. 102: 8692–8697.
29. Xu Q., Dewey S., Nguyen S., Gomes A.V. Malignant and be- ning mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes // J. Mol. Cell. Cardiol., 2010 May. Vol. 48 (5). P. 899–909.
30. Zemljic-Harpf A., Miller J.C., Henderson S.A. et al. Car- diac – myocyte-specific excisition of the vinculin gene disrupts cellular junctions, causing sudden death or di- lated cardiomyopathy // Mol. Cell. Biol. 2007. Vol. 27. P. 7522–7537.
31. Zemljic-Harpf A., Manso A.M., Ross S.R. Vinculin and Talin: Focus on the Myocardium // J. Investig. Med. 2009. Vol. 57 (8). P. 849–855.
32. Zhao P., Sharma A.C., Ren J. Pathogenesis and thera- py of autoimmunithy-induced dilated cardiomyopathy // Front Biosci. 2009 Jan 1. Vol. 14. P. 1708–1715.
Review
For citations:
Kupriyanova A.G., Beletskaya L.V., Zaidenov V.A., Saitgareev R.Sh., Golts A.M., Zakharevich V.M., Gautier S.V. EVALUATION OF THE MACROMOLECULAR STRUCTURE OF CARDIAC MYOCYTES IN PATIENTS WITH VARIOUS FORMS OF CARDIOMYOPATHY. Russian Journal of Transplantology and Artificial Organs. 2012;14(2):32-42. (In Russ.) https://doi.org/10.15825/1995-1191-2012-2-32-42
Views:
726
Email this article 